Skip to content

Clinical trials

Phase 1 Esophageal Neoplasms trials in France

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Esophageal Neoplasms Phase: Phase 1 Country / region: France Clear all

13 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20091
20151
20201
20211
20223
20231
20243
20251
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Active, not recruiting5
Recruiting5
Completed2
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Eli Lilly and Company4
Novartis Pharmaceuticals2
Bristol-Myers Squibb1
Institut Paoli-Calmettes1
Pfizer1
Revolution Medicines, Inc.1
Seagen Inc.1
Seagen, a wholly owned subsidiary of Pfizer1
SystImmune Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Esophageal Neoplasms13
Ovarian Neoplasms9
Carcinoma, Non-Small-Cell Lung8
Endometrial Neoplasms6
Neoplasm Metastasis6
Stomach Neoplasms6
Colorectal Neoplasms5
Lung Neoplasms5
Pancreatic Neoplasms5
Squamous Cell Carcinoma of Head and Neck5

Trials

Showing 1 to 13 of 13. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.